Annual Shareholders Equity
$39.70 M
-$14.87 M-27.25%
31 December 2023
Summary:
Theriva Biologics annual stockholders equity is currently $39.70 million, with the most recent change of -$14.87 million (-27.25%) on 31 December 2023. During the last 3 years, it has risen by +$31.67 million (+394.30%). TOVX annual shareholders equity is now -39.31% below its all-time high of $65.41 million, reached on 31 December 2021.TOVX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$24.64 M
-$3.01 M-10.89%
01 September 2024
Summary:
Theriva Biologics quarterly stockholders equity is currently $24.64 million, with the most recent change of -$3.01 million (-10.89%) on 01 September 2024. Over the past year, it has dropped by -$19.25 million (-43.86%). TOVX quarterly shareholders equity is now -69.05% below its all-time high of $79.60 million, reached on 01 March 2021.TOVX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TOVX Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -27.3% | -43.9% |
| 3 y3 years | +394.3% | -62.3% |
| 5 y5 years | +176.3% | +71.5% |
TOVX Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -39.3% | +394.3% | -63.8% | at low |
| 5 y | 5 years | -39.3% | +394.3% | -69.0% | +268.7% |
| alltime | all time | -39.3% | +358.0% | -69.0% | +251.7% |
Theriva Biologics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $24.64 M(-10.9%) |
| June 2024 | - | $27.65 M(-19.0%) |
| Mar 2024 | - | $34.12 M(-14.0%) |
| Dec 2023 | $39.70 M(-27.2%) | $39.70 M(-9.5%) |
| Sept 2023 | - | $43.88 M(-8.1%) |
| June 2023 | - | $47.75 M(-5.6%) |
| Mar 2023 | - | $50.59 M(-7.3%) |
| Dec 2022 | $54.56 M(-16.6%) | $54.56 M(-6.2%) |
| Sept 2022 | - | $58.15 M(-5.7%) |
| June 2022 | - | $61.67 M(-9.3%) |
| Mar 2022 | - | $68.03 M(+4.0%) |
| Dec 2021 | $65.41 M(+714.4%) | - |
| Dec 2021 | - | $65.41 M(-10.8%) |
| Sept 2021 | - | $73.33 M(-4.1%) |
| June 2021 | - | $76.50 M(-3.9%) |
| Mar 2021 | - | $79.60 M(+891.1%) |
| Dec 2020 | $8.03 M(-44.1%) | $8.03 M(+20.2%) |
| Sept 2020 | - | $6.68 M(-23.2%) |
| June 2020 | - | $8.70 M(-24.2%) |
| Mar 2020 | - | $11.48 M(-20.1%) |
| Dec 2019 | $14.37 M(-51.1%) | $14.37 M(-17.5%) |
| Sept 2019 | - | $17.41 M(-22.4%) |
| June 2019 | - | $22.44 M(-13.3%) |
| Mar 2019 | - | $25.88 M(-11.9%) |
| Dec 2018 | $29.36 M(+178.1%) | $29.36 M(+245.4%) |
| Sept 2018 | - | $8.50 M(+49.5%) |
| June 2018 | - | $5.69 M(-36.3%) |
| Mar 2018 | - | $8.93 M(-15.4%) |
| Dec 2017 | $10.56 M(+174.6%) | $10.56 M(-320.5%) |
| Sept 2017 | - | -$4.79 M(-199.1%) |
| June 2017 | - | $4.83 M(+88.0%) |
| Mar 2017 | - | $2.57 M(-33.2%) |
| Dec 2016 | $3.85 M(-76.0%) | $3.85 M(-185.9%) |
| Sept 2016 | - | -$4.48 M(-295.1%) |
| June 2016 | - | $2.29 M(-63.3%) |
| Mar 2016 | - | $6.26 M(-61.0%) |
| Dec 2015 | $16.05 M(+68.0%) | $16.05 M(-38.0%) |
| Sept 2015 | - | $25.87 M(-289.4%) |
| June 2015 | - | -$13.66 M(+740.7%) |
| Mar 2015 | - | -$1.63 M(-117.0%) |
| Dec 2014 | $9.56 M(-37.3%) | $9.56 M(+154.4%) |
| Sept 2014 | - | $3.76 M(-53.4%) |
| June 2014 | - | $8.06 M(-31.5%) |
| Mar 2014 | - | $11.76 M(-22.8%) |
| Dec 2013 | $15.23 M(+16.9%) | $15.23 M(+139.1%) |
| Sept 2013 | - | $6.37 M(-32.2%) |
| June 2013 | - | $9.40 M(-18.2%) |
| Mar 2013 | - | $11.49 M(-11.8%) |
| Dec 2012 | $13.03 M(+84.6%) | $13.03 M(+140.9%) |
| Sept 2012 | - | $5.41 M(-21.0%) |
| June 2012 | - | $6.85 M(-13.4%) |
| Mar 2012 | - | $7.91 M(+12.0%) |
| Dec 2011 | $7.06 M(+97.2%) | $7.06 M(-16.4%) |
| Sept 2011 | - | $8.44 M(-7.5%) |
| June 2011 | - | $9.12 M(+51.9%) |
| Mar 2011 | - | $6.01 M(+67.8%) |
| Dec 2010 | $3.58 M | $3.58 M(-15.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2010 | - | $4.24 M(+10.3%) |
| June 2010 | - | $3.84 M(+38.6%) |
| Mar 2010 | - | $2.77 M(-21.8%) |
| Dec 2009 | $3.54 M(-47.6%) | $3.54 M(-23.4%) |
| Sept 2009 | - | $4.63 M(-10.3%) |
| June 2009 | - | $5.16 M(-12.7%) |
| Mar 2009 | - | $5.91 M(-12.6%) |
| Dec 2008 | $6.76 M(-43.4%) | $6.76 M(-10.2%) |
| Sept 2008 | - | $7.53 M(-12.4%) |
| June 2008 | - | $8.60 M(-9.7%) |
| Mar 2008 | - | $9.52 M(-20.3%) |
| Dec 2007 | $11.95 M(+1.3%) | $11.95 M(+58.0%) |
| Sept 2007 | - | $7.56 M(-16.5%) |
| June 2007 | - | $9.05 M(-13.4%) |
| Mar 2007 | - | $10.45 M(-11.3%) |
| Dec 2006 | $11.79 M(-1774.7%) | $11.79 M(<-9900.0%) |
| Sept 2006 | - | -$3000.00(-106.0%) |
| June 2006 | - | $49.70 K(-628.7%) |
| Mar 2006 | - | -$9400.00(-99.9%) |
| Dec 2005 | -$703.80 K(-95.4%) | - |
| Mar 2003 | - | -$16.24 M(+5.6%) |
| Dec 2002 | -$15.39 M(+69.3%) | -$15.39 M(+6.9%) |
| Sept 2002 | - | -$14.39 M(+9.8%) |
| June 2002 | - | -$13.11 M(+19.4%) |
| Mar 2002 | - | -$10.98 M(+20.9%) |
| Dec 2001 | -$9.09 M(+2096.4%) | -$9.09 M(+65.0%) |
| Sept 2001 | - | -$5.51 M(+95.0%) |
| June 2001 | - | -$2.82 M(+47.3%) |
| Mar 2001 | - | -$1.92 M(+363.6%) |
| Dec 2000 | -$413.70 K(-161.6%) | -$413.70 K(-40.4%) |
| Sept 2000 | - | -$694.70 K(+245.3%) |
| June 2000 | - | -$201.20 K(-109.1%) |
| Mar 2000 | - | $2.21 M(+229.6%) |
| Dec 1999 | $671.10 K(-4.1%) | $671.10 K(-121.0%) |
| Sept 1999 | - | -$3.20 M(+88.2%) |
| June 1999 | - | -$1.70 M(+240.0%) |
| Mar 1999 | - | -$500.00 K(-171.4%) |
| Dec 1998 | $700.00 K(-131.8%) | $700.00 K(-56.3%) |
| Sept 1998 | - | $1.60 M(-66.7%) |
| June 1998 | - | $4.80 M(-229.7%) |
| Mar 1998 | - | -$3.70 M(+68.2%) |
| Dec 1997 | -$2.20 M(-229.4%) | -$2.20 M(+37.5%) |
| Sept 1997 | - | -$1.60 M(-1700.0%) |
| June 1997 | - | $100.00 K(-95.0%) |
| Mar 1997 | - | $2.00 M(+17.6%) |
| Dec 1996 | $1.70 M(-5.6%) | $1.70 M(-56.4%) |
| Sept 1996 | - | $3.90 M(-20.4%) |
| June 1996 | - | $4.90 M(+145.0%) |
| Mar 1996 | - | $2.00 M(+11.1%) |
| Dec 1995 | $1.80 M(-400.0%) | $1.80 M(-40.0%) |
| Sept 1995 | - | $3.00 M(-600.0%) |
| Dec 1994 | -$600.00 K(-135.3%) | -$600.00 K(-113.3%) |
| Mar 1994 | - | $4.50 M(+164.7%) |
| Dec 1993 | $1.70 M | $1.70 M(-41.4%) |
| Sept 1993 | - | $2.90 M(-31.0%) |
| June 1993 | - | $4.20 M(+2.4%) |
| Mar 1993 | - | $4.10 M |
FAQ
- What is Theriva Biologics annual stockholders equity?
- What is the all time high annual shareholders equity for Theriva Biologics?
- What is Theriva Biologics annual shareholders equity year-on-year change?
- What is Theriva Biologics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Theriva Biologics?
- What is Theriva Biologics quarterly shareholders equity year-on-year change?
What is Theriva Biologics annual stockholders equity?
The current annual shareholders equity of TOVX is $39.70 M
What is the all time high annual shareholders equity for Theriva Biologics?
Theriva Biologics all-time high annual stockholders equity is $65.41 M
What is Theriva Biologics annual shareholders equity year-on-year change?
Over the past year, TOVX annual stockholders equity has changed by -$14.87 M (-27.25%)
What is Theriva Biologics quarterly stockholders equity?
The current quarterly shareholders equity of TOVX is $24.64 M
What is the all time high quarterly shareholders equity for Theriva Biologics?
Theriva Biologics all-time high quarterly stockholders equity is $79.60 M
What is Theriva Biologics quarterly shareholders equity year-on-year change?
Over the past year, TOVX quarterly stockholders equity has changed by -$19.25 M (-43.86%)